Portfolio
Since 2008 the Royal Society Enterprise Fund has invested in a portfolio of five companies.
Professor Wilhelm Huck, Professor Chris Abell and Dr Frank Craig of Sphere Fluidics. Image copyright: Cambridge Enterprise.
- OrganOx: has developed a process which allows donated livers to be preserved for longer periods during storage and transportation, thereby significantly increasing the supply of organs for life-saving transplant operations.
- Base4Innovation: is developing a radically new method of ultra-fast DNA sequencing using techniques based on silicon chip technology.
- N-PSL: is manufacturing novel and compact filtration technology that improves energy consumption in a wide range of industrial applications, including compressed air treatment.
- Sphere Fluidics: is developing miniature droplet technology that enables ultra-rapid chemical analysis of cells and molecules, applicable to a wide range of markets including drug development, biocatalysts and algal biofuels.